Overview
Mid-dermal elastolysis (MDE) is a rare acquired disorder of elastic tissue characterized by the selective loss of elastic fibers in the mid-dermis (the middle layer of the skin's connective tissue). The condition predominantly affects young to middle-aged women, though cases in men have been reported. It presents clinically with areas of fine wrinkling or perifollicular papular protrusions on the trunk, upper arms, neck, and occasionally other body areas. The skin in affected regions appears thin, lax, and finely wrinkled, giving a prematurely aged appearance. Two main clinical patterns have been described: a diffuse fine wrinkling type and a perifollicular papular type. The condition is generally limited to the skin and does not involve internal organs. The exact cause of mid-dermal elastolysis remains unknown. It has been associated with sun exposure, and some cases have been linked to inflammatory processes or autoimmune conditions, though no consistent underlying etiology has been established. Histologically, the hallmark finding is a band-like loss of elastic fibers in the mid-dermis, with preservation of elastic fibers in the superficial (papillary) and deep (reticular) dermis. There may be a mild perivascular inflammatory infiltrate. The condition is distinct from other elastolytic disorders such as anetoderma, cutis laxa, and granulomatous slack skin. Currently, there is no established curative treatment for mid-dermal elastolysis. The condition is generally considered benign and primarily of cosmetic concern, though it can be psychologically distressing for affected individuals. Various treatments have been attempted with limited success, including topical retinoids, sun protection, and anti-inflammatory agents. Some reports have described partial improvement with dapsone or colchicine in cases with an inflammatory component. Sun avoidance and photoprotection are generally recommended. The prognosis is favorable in terms of overall health, but the skin changes tend to be progressive and persistent.
Sporadic
Usually appears on its own, not inherited from a parent
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for Mid-dermal elastolysis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Mid-dermal elastolysis at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Mid-dermal elastolysis.
Community
No community posts yet. Be the first to share your experience with Mid-dermal elastolysis.
Start the conversation →Latest news about Mid-dermal elastolysis
No recent news articles for Mid-dermal elastolysis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Mid-dermal elastolysis
What is Mid-dermal elastolysis?
Mid-dermal elastolysis (MDE) is a rare acquired disorder of elastic tissue characterized by the selective loss of elastic fibers in the mid-dermis (the middle layer of the skin's connective tissue). The condition predominantly affects young to middle-aged women, though cases in men have been reported. It presents clinically with areas of fine wrinkling or perifollicular papular protrusions on the trunk, upper arms, neck, and occasionally other body areas. The skin in affected regions appears thin, lax, and finely wrinkled, giving a prematurely aged appearance. Two main clinical patterns have b
How is Mid-dermal elastolysis inherited?
Mid-dermal elastolysis follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Mid-dermal elastolysis typically begin?
Typical onset of Mid-dermal elastolysis is adult. Age of onset can vary across affected individuals.
Which specialists treat Mid-dermal elastolysis?
15 specialists and care centers treating Mid-dermal elastolysis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.